In vivo Cell-Specific Exosome Analysis
In vivo Cell-Specific Exosome Analysis
批准号:
10231459
负责人:
Mehboob A Hussain
金额:
$19.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-01 至 2023-01-31
关键词:
AddressAgeAgingAntibodiesAntidiabetic DrugsAntigensBackBenchmarkingBeta CellBiologicalBiological ModelsBlood CirculationCaliberCell physiologyCellsChronologyCodeComplementComplementary DNACultured CellsDiabetes MellitusDiagnosticDietary InterventionEarly DiagnosisExcisionExhibitsExtracellular DomainFoundationsFunctional disorderGeneticGenetic TranscriptionIn VitroInjuryInsulin ResistanceInterventionKnowledgeLabelLife Cycle StagesLiquid substanceMediatingMembraneMetabolicMetabolic stressMicroRNAsModelingMolecularMusOrganellesOrganismOutcomeOutcome StudyPHluorinPathologicPharmacologyPhysiologicalPlasmaPopulationPropertyRNASamplingSignal TransductionStructure of beta Cell of isletSurfaceTestingTherapeutic EffectTherapeutic InterventionTimebasecell agecell typecohortdiet-induced obesitydietaryengineered exosomesexenatideexosomeglycemic controlin vivoinsulin secretionintercellular communicationisletliquid biopsymolecular markermouse modelnovelrecombinase-mediated cassette exchangeresponseselective expressionsextooltreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Exosomes are small single-membrane secreted organelles of approximately 30-150 nm in diameter
that are secreted by most, if not all cells. There is a growing appreciation that exosomes are an important part of inter-cellular communication and that cargo carried by exosomes transmit a variety of signaling properties from their cell of origin to cells that receive exosome cargo. Further, the exosome cargo released from a specific cell-type may reflect the physiologic state of that particular cell population. Most studies on exosomes rely on isolating exosomes from cultured cells or cell clusters in vitro, or bulk exosome isolation from in vivo sampling of biological fluids (such as plasma). However, there exist no simple tools that allow to in vivo isolate and examine exosomes that can be traced back to a specific cell of origin and which can be sampled longitudinally over time within the same organism. Thus, we have little information on how exosomes and their cargo released from a certain cell changes with ageing during the course of the life of an organism or how the exosome cargo may change if a particular cell-type responds to increased functional demand and/or injury. To address these questions, we have generated a mouse model that permits conditional and cell-selective genetic labeling of exosomes through expression of an engineered exosome surface marker. We have used a cDNA cassette in which the coding sequence of a green-fluorescent tag (pHluorin) is inserted into the first extracellular domain of the tetraspanin CD63, which is highly enriched in and expressed on the surface of exosomes. We have inserted this cassette into the Rosa26 locus allowing it to be conditionally expressed in a cell-specific manner after CRE-mediated removal of upstream transcriptional stop sequences (= R26-
StopLoxP-CD63-pHluorin mouse). From plasma of these mice, using an antibody that recognizes pHluorin antigen, we can isolate and capture exosomes that can be traced back to their cell of origin. This unique mouse model represents a significant advance over existing means to study exosomes in vivo in a cell-selective manner. We have chosen to study exosomes released from pancreatic ß-cells, as these cells are known to undergo distinct functional and molecular changes with ageing and under different physiologic and pathologic conditions. In this exploratory proposal we aim to use our model system to examine whether and how the exosome cargo from pancreatic ß-cells in mice changes over their lifetime and during circumstances of altered metabolic demand. At the molecular level we will focus our proof-of-principle studies on examining changes in
RNA levels in ß-cells and in circulating ß-cell-derived exosomes. The outcomes of these studies will increase our knowledge on whether exosomes accurately reflect the age and functional state of the pancreatic ß-cell and whether exosomes and their cargo could be utilized as diagnostic tools for early detection of cellular dysfunction and response to treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
-
批准号:10313849
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2021
-
负责人:Mehboob A Hussain
-
依托单位:
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
-
批准号:10619654
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2021
-
负责人:Mehboob A Hussain
-
依托单位:
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
-
批准号:10427438
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2021
-
负责人:Mehboob A Hussain
-
依托单位:
In vivo Cell-Specific Exosome Analysis
-
批准号:10398194
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2021
-
负责人:Mehboob A Hussain
-
依托单位:
Glucagon signaling in metabolic homeostasis
-
批准号:10424554
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2020
-
负责人:Mehboob A Hussain
-
依托单位:
Glucagon signaling in metabolic homeostasis
-
批准号:10261596
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2020
-
负责人:Mehboob A Hussain
-
依托单位:
Hepatic endocrine suppression of the pancreatic beta-cell
-
批准号:8817887
-
项目类别:
-
资助金额:$51.18万
-
财政年份:2014
-
负责人:Mehboob A Hussain
-
依托单位:
Hepatic endocrine suppression of the pancreatic beta-cell
-
批准号:9671615
-
项目类别:
-
资助金额:$36.51万
-
财政年份:2014
-
负责人:Mehboob A Hussain
-
依托单位:
Control of hepatic and b-cell function by co-activators
-
批准号:8010071
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2010
-
负责人:Mehboob A Hussain
-
依托单位:
High-Throughput Screen For FDA Approved Drugs That Amplify Beta-Cell Mass In Vivo
-
批准号:8045193
-
项目类别:
-
资助金额:$252.44万
-
财政年份:2010
-
负责人:Mehboob A Hussain
-
依托单位:
Endocrine pancreatic cell regeneration from bone marrow
-
批准号:7993160
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2010
-
负责人:Mehboob A Hussain
-
依托单位:
Beta-cell Proliferation
-
批准号:7652057
-
项目类别:
-
资助金额:$45.1万
-
财政年份:2009
-
负责人:Mehboob A Hussain
-
依托单位:
Beta-cell Proliferation
-
批准号:8272634
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2009
-
负责人:Mehboob A Hussain
-
依托单位:
Beta-cell Proliferation
-
批准号:8070500
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2009
-
负责人:Mehboob A Hussain
-
依托单位:
Beta-cell Proliferation
-
批准号:8452098
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2009
-
负责人:Mehboob A Hussain
-
依托单位:
Beta-cell Proliferation
-
批准号:7864157
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2009
-
负责人:Mehboob A Hussain
-
依托单位:
CORE A: CELL BIOLOGY CORE
-
批准号:8868982
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2008
-
负责人:Mehboob A Hussain
-
依托单位:
CORE A: CELL BIOLOGY CORE
-
批准号:9221320
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2008
-
负责人:Mehboob A Hussain
-
依托单位:
JHU-UMD Diabetes Research Center
-
批准号:9000687
-
项目类别:
-
资助金额:$194.28万
-
财政年份:2008
-
负责人:Mehboob A Hussain
-
依托单位:
CORE A: CELL BIOLOGY CORE
-
批准号:8443952
-
项目类别:
-
资助金额:$21.8万
-
财政年份:2008
-
负责人:Mehboob A Hussain
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: